Nectar Lifesciences
Update in progressNECLIFE.NS (NSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Nectar Lifesciences Limited manufactures, distributes, markets and sells pharmaceutical products in India and abroad. It provides cephalosporin active ingredients and intermediates, including cefixime, cefuroxime axetil (amorphous and crystalline), cefotaxime sodium, ceftriaxone sodium, cefdinir, cefpodoxime proxetil, cefprozil, cefazolin sodium, ceftazidime pentahydrate, and cefepime with arginine. It also offers contract manufacturing for finished dosage forms and injectables, plus menthol and pearl capsules. Incorporated 1995, headquartered in Chandigarh.
Company score
- Sentiment
- -0.04
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.09
- Governance
- -0.07
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.04
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.04
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!